Chimeric Therapeutics Limited TempASX: CHMDA

Quarterly Activities/Appendix 4C Cash Flow Report

Apr 29, 2026 at 10:02 AM UTC · Issued by Chimeric Therapeutics Limited Temp

Chimeric Therapeutics Limited Temp has released a press release.

View Attachment

Earlier from Chimeric Therapeutics Limited Temp

CHM CORE-NK Phase 1B clinical trial achieves 60% CR/CRiApr 27

All Chimeric Therapeutics Limited Temp news releases